Real World Data Study Finds Comprehensive Genomic Profiling Improves Cancer Outcomees

Real-world data (RWD) to be presented at this year’s upcoming American Society of Clinical Oncology’s Annual Meeting shows that comprehensive genomic profiling (CGP) improves cancer patients’ outcomes. The study, which covered 1,423 advanced cancer patients who received CGP from 2019 to 2021, showed that CGP was associated with improved survival.

According to Illumina, “While CGP is increasingly included in care guidelines, the inconsistent application of CGP creates a major gap in the standard-of-care practice for advanced cancer. In order to understand the benefit of more consistent use of CGP, Providence, a not-for-profit health system serving the Western US, implemented a reflex testing protocol where CGP was routinely ordered by pathologists at time of diagnosis for advanced cancer patients.”

To read more, click here.

(Source: PR Newswire, May 30^th, 2023)